500674 Stock Overview
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Sanofi India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹6,081.15 |
| 52 Week High | ₹10,526.05 |
| 52 Week Low | ₹5,850.55 |
| Beta | 0.28 |
| 11 Month Change | -8.04% |
| 3 Month Change | -11.24% |
| 1 Year Change | -23.62% |
| 33 Year Change | -25.63% |
| 5 Year Change | -13.08% |
| Change since IPO | 1,637.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500674 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.6% | -0.2% | 0.3% |
| 1Y | -23.6% | 40.5% | 27.3% |
Return vs Industry: 500674 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 500674 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 500674 volatility | |
|---|---|
| 500674 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500674 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500674's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 2,174 | Rodolfo Hrosz | www.sanofiindialtd.com |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries.
Sanofi India Limited Fundamentals Summary
| 500674 fundamental statistics | |
|---|---|
| Market cap | ₹141.61b |
| Earnings (TTM) | ₹5.30b |
| Revenue (TTM) | ₹28.23b |
26.4x
P/E Ratio5.0x
P/S RatioIs 500674 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500674 income statement (TTM) | |
|---|---|
| Revenue | ₹28.23b |
| Cost of Revenue | ₹12.14b |
| Gross Profit | ₹16.09b |
| Other Expenses | ₹10.78b |
| Earnings | ₹5.30b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 230.30 |
| Gross Margin | 56.99% |
| Net Profit Margin | 18.79% |
| Debt/Equity Ratio | 3.2% |
How did 500674 perform over the long term?
See historical performance and comparison